UK HealthCare

Drew Micciche named 2024-25 Bell Addiction Medicine Scholar

Drew Micciche
Drew Micciche, M.D., has been selected as UK’s Bell Addiction Medicine Scholar for 2024-2025. Photo provided.

LEXINGTON, Ky. (Aug. 19, 2024) — Drew Micciche, M.D., an assistant professor in the University of Kentucky College of Medicine’s Department of Emergency Medicine and an attending physician on UK’s Addiction Consult and Education Services, has been selected as UK’s Bell Addiction Medicine Scholar for 2024-2025.  

The mission of the Bell Alcohol and Addiction Endowed Chair is to build a broader base of physician education and training experiences in treating patients with substance use disorders at UK HealthCare. 

Micciche’s focus during his year as the Bell Addiction Medicine Scholar will be multifaceted, addressing several key areas in addiction medicine. He plans to work with staff and providers to increase the initiation of buprenorphine within the emergency department, ensure its appropriate continuation for admitted patients, implement new workflows for providing fentanyl test strips to at-risk patients, and enhance the quality of outpatient resources provided to patients with substance use disorder upon discharge from the emergency department. 

Micciche serves as a UK toxicology and hyperbaric medicine consultant and works for the Kentucky Poison Control Center. He also regularly teaches and mentors residents and medical students at various levels of training. His primary clinical interests include diagnosing and managing poisoned and envenomated patients and treating patients with substance use disorders. 

Micciche completed his M.D. at the UK College of Medicine. Following his medical education, Micciche pursued residency training in emergency medicine at the University of Pittsburgh Medical Center and completed a fellowship in medical toxicology at the same institution. 

After completing his training, Micciche returned to Lexington to join the clinical faculty at UK. His diverse roles within UK HealthCare underscore his commitment to advancing patient care and medical education in emergency medicine and addiction treatment. 

UK HealthCare is the hospitals and clinics of the University of Kentucky. But it is so much more. It is more than 10,000 dedicated health care professionals committed to providing advanced subspecialty care for the most critically injured and ill patients from the Commonwealth and beyond. It also is the home of the state’s only National Cancer Institute (NCI)-designated Comprehensive Cancer Center, a Level IV Neonatal Intensive Care Unit that cares for the tiniest and sickest newborns, the region’s only Level 1 trauma center and Kentucky’s top hospital ranked by U.S. News & World Report.

As an academic research institution, we are continuously pursuing the next generation of cures, treatments, protocols and policies. Our discoveries have the potential to change what’s medically possible within our lifetimes. Our educators and thought leaders are transforming the health care landscape as our six health professions colleges teach the next generation of doctors, nurses, pharmacists and other health care professionals, spreading the highest standards of care. UK HealthCare is the power of advanced medicine committed to creating a healthier Kentucky, now and for generations to come.